Skip to main content

Table 3 Laboratory characteristics of participants with GDM vs. controls

From: The risk of metabolic syndrome after gestational diabetes mellitus – a hospital-based cohort study

  GDM Control p value
(n = 119) (n = 120)
Leucocytes, 109/L 5.8 ± 1.6 5.2 ± 1.4 0.008
Haemoglobin, g/L 133.2 ± 9.3 128.6 ± 12.9 0.001
Platelets, 109/L 241.9 ± 58.2 244.0 ± 52.5 NS
ALAT, U/L 22.8 ± 17.4 19.7 ± 10.5 NS
Creatinine, umol/L 66.6 ± 7.7 64.5 ± 7.8 0.048
U-AlbCre, mg/mmol 0.67 ± 0.5 0.57 ± 0.3 NS (0.070)
Fibrinogen, g/L 3.4 ± 0.9 3.2 ± 1.0 NS (0.096)
Fasting glucose, mmol/L 5.6 ± 0.6 5.3 ± 0.3 < 0.001
Total cholesterol, mmol/L 4.7 ± 0.9 4.6 ± 0.8 NS
HDL cholesterol, mmol/L 1.5 ± 0.3 1.6 ± 0.3 NS
LDL cholesterol, mmol/L 3.0 ± 0.7 2.8 ± 0.6 NS
Triglycerides, mmol/L 1.1 ± 0.6 0.9 ± 0.4 < 0.001
  1. Data are presented as mean ± SD.
  2. U-AlbCre: urinary albumin to creatinine ratio, ALAT: alanine transaminase.